Antimelanoma Effect of 4S-Cysteaminylcatechol , an Activated Form of 4-5-Cysteaminylphenol 1
暂无分享,去创建一个
Hasegawa | Shigeki | Ozeki | Keisuke | Kazumasa | Ito | Francisco | Fujita | C. Jiménez‐Cervantes | Hiroyuki | Solano | Katsutoshi | Inoue | Shosuke | Wakamatsu
[1] S. Ito,et al. In vivo antimelanoma effects of 4-S-cysteaminylphenol, a newly synthesized therapeutic agent specific to melanoma , 2005, Journal of Cancer Research and Clinical Oncology.
[2] G. Sanborn,et al. Efficacy of Dacarbazine (DTIC) in preventing metastases arising from intraocular melanomas in mice , 1992, Graefe's Archive for Clinical and Experimental Ophthalmology.
[3] K. Jimbow,et al. Synthesis of cysteinylphenol, cysteaminylphenol, and related compounds, and in vivo evaluation of antimelanoma effect , 2004, Archives of Dermatological Research.
[4] W. Bloomer,et al. Thymidylate synthase as a target enzyme for the melanoma-specific toxicity of 4-S-cysteaminylphenol andN-acetyl-4-S-cysteaminylphenol , 2004, Cancer Chemotherapy and Pharmacology.
[5] D. Mascagna,et al. Melanogenesis as a targeting strategy against metastatic melanoma: a reassessment , 1994, Melanoma research.
[6] K. Urabe,et al. A new enzymatic function in the melanogenic pathway. The 5,6-dihydroxyindole-2-carboxylic acid oxidase activity of tyrosinase-related protein-1 (TRP1). , 1994, The Journal of biological chemistry.
[7] K. Wakamatsu,et al. An improved modification of permanganate oxidation of eumelanin that gives a constant yield of pyrrole-2,3,5-tricarboxylic acid. , 1994, Pigment cell research.
[8] K. Jimbow,et al. Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine. , 1994, Cancer research.
[9] F. Solano,et al. Tyrosinase isoenzymes in mammalian melanocytes. 1. Biochemical characterization of two melanosomal tyrosinases from B16 mouse melanoma. , 1993, European journal of biochemistry.
[10] K. Jimbow,et al. Selective in vivo and in vitro incorporation and accumulation of phenolic thioether amine into malignant melanoma and identification of a (58 kD) binding glycoprotein , 1992, Melanoma research.
[11] V. Marmol,et al. Glutathione depletion in mouse melanoma cells increases their sensitivity to oxidative lysis , 1992 .
[12] G. Prota,et al. Melanins and melanogenesis , 1992 .
[13] A. Winder,et al. New assays for the tyrosine hydroxylase and dopa oxidase activities of tyrosinase. , 1991, European journal of biochemistry.
[14] S. Ito,et al. Action of cysteaminylphenols on human melanoma cells in vivo and in vitro: 4‐S‐cysteaminylphenol binds protein disulphide isomerase , 1991, Melanoma research.
[15] S. Ito,et al. The killing effect of 4-S-cysteaminylphenol, a newly synthesised melanin precursor, on B16 melanoma cell lines. , 1991, British Journal of Cancer.
[16] Platts-Mills Tae,et al. Melanogenesis: a Realistic Target for Antimelanoma Therapy? , 1991 .
[17] S. Ito,et al. The in vivo antimelanoma effect of 4‐S‐cysteaminylphenol and its N‐acetyl derivative , 1990, International journal of cancer.
[18] S. Ito,et al. 4-S-cysteaminylphenol and its analogues as substrates for tyrosinase and monoamine oxidase. , 1990, Pigment cell research.
[19] S. Ito,et al. Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo. , 1990, Cancer research.
[20] K. Wakamatsu,et al. Mechanism of growth inhibition of melanoma cells by 4-S-cysteaminylphenol and its analogues. , 1990, Biochemical pharmacology.
[21] F. Solano,et al. Assays for mammalian tyrosinase: a comparative study. , 1988, Pigment cell research.
[22] Ito Shosuke,et al. Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes , 1987 .
[23] J. Pawelek,et al. Increase in melanin formation and promotion of cytotoxicity in cultured melanoma cells caused by phosphorylated isomers of L-dopa. , 1986, Cancer research.
[24] J. Han,et al. ANTIHYPERTENSIVE ACTIVITIES OF PHENYL AMINOETHYL SULFIDES, A CLASS OF SYNTHETIC SUBSTRATES FOR DOPAMINE β-HYDROXYLASE , 1985 .
[25] S. Ito,et al. Microanalysis of eumelanin and pheomelanin in hair and melanomas by chemical degradation and liquid chromatography. , 1985, Analytical biochemistry.
[26] P. Riley. Hydroxyanisole : recent advances in anti-melanoma therapy , 1984 .
[27] Y. Yamamoto,et al. Synthesis and antitumor activity of cysteinyl-3,4-dihydroxyphenylalanines and related compounds. , 1981, Journal of medicinal chemistry.
[28] M. Wick. 3,4-Dihydroxybenzylamine: a dopamine analog with enhanced antitumor activity against B16 melanoma. , 1979, Journal of the National Cancer Institute.
[29] M. Wick,et al. L-dopa: selective toxicity for melanoma cells in vitro. , 1977, Science.
[30] R. Geran,et al. PROTOCOLS FOR SCREENING CHEMICAL AGENTS AND NATURAL PRODUCTS AGAINST ANIMAL TUMORS AND OTHER BIOLOGICAL SYSTEMS , 1972 .
[31] P. A. Riley. Hydroxyanisole depigmentation: In‐vivo studies , 1969, The Journal of pathology.
[32] P. Hochstein,et al. THE CYTOTOXICITY OF MELANIN PRECURSORS * , 1963, Annals of the New York Academy of Sciences.